首页> 外文学位 >Statistical Estimation of Physiologically-based Pharmacokinetic Models: Identifiability, Variation, and Uncertainty with an Illustration of Chronic Exposure to Dioxin and Dioxin-like-compounds.
【24h】

Statistical Estimation of Physiologically-based Pharmacokinetic Models: Identifiability, Variation, and Uncertainty with an Illustration of Chronic Exposure to Dioxin and Dioxin-like-compounds.

机译:基于生理学的药代动力学模型的统计估计:可识别性,变异性和不确定性,并举例说明了长期暴露于二恶英和类似二恶英的化合物。

获取原文
获取原文并翻译 | 示例

摘要

Assessment of human exposure to environmental chemicals is inherently subject to uncertainty and variability. There are data gaps concerning the inventory, source, duration, and intensity of exposure as well as knowledge gaps regarding pharmacokinetics in general. These gaps result in uncertainties in exposure assessment. The uncertainties compound further with variabilities due to population variations regarding stage of life, life style, and susceptibility, etc. Use of physiologically-based pharmacokinetic (PBPK) models promises to reduce the uncertainties and enhance extrapolation between species, between routes, from high to low dose, and from acute to chronic exposure. However, fitting PBPK models is challenging because of a large number of biochemical and physiological parameters to be estimated. Many of these model parameters are non-identifiable in that their estimates cannot be uniquely determined using statistical criteria. In practice some parameters are fixed in value and some determined through mathematical calibration or computer simulation. These estimated values are subject to substantial uncertainties. The first part of this paper illustrates the use of iteratively-reweighted-nonlinear-least-squares for fitting pharmacokinetic (PK) models, highlighting some common difficulties in obtaining statistical estimates of non-identifiable parameters and use bootstrap confidence interval to quantify uncertainties.;Statistical estimation of parameters in physiologically based pharmacokinetic (PBPK) models is a relatively new area of research. Over the past decade or so PBPK models have become important and valuable tools in risk assessment as these models are used to describe the absorption, distribution, metabolism, and excretion of xenobiotics in a biological system such as the human or rat. Because these models incorporate information on biological processes, they are well equipped to describe the kinetic behaviors of chemicals and are useful for extrapolation across dose routes, between species, from high-to-low-doses, and across exposure scenarios.;A PBPK model has been developed based on published models in the literature to describe the absorption, distribution, metabolism, and excretion of Dioxin and dioxin like compounds (DLCs) in the rat. Data from the National Toxicology Program (NTP) two year experiment TR-526 is used to illustrate model fitting and statistical estimation of the parameters. Integrating statistical methods into risk assessments is the most efficient way to characterize the variation in parameter values. In this dissertation a Markov Chain Monte Carlo (MCMC) method is used to estimate select parameters of the system and to describe the variation of the select parameters.
机译:对人类暴露于环境化学物质的评估固有地具有不确定性和可变性。一般而言,存在有关清单,来源,持续时间和暴露强度的数据缺口,以及有关药代动力学的知识缺口。这些差距导致暴露评估的不确定性。由于种群在生活阶段,生活方式和易感性等方面的变化,不确定性进一步加剧。基于生理的药代动力学(PBPK)模型的使用有望减少不确定性,并增强物种之间,路线之间,从高到高的推断。低剂量,从急性到慢性暴露。但是,由于要估算大量的生化和生理参数,因此拟合PBPK模型具有挑战性。这些模型参数中的许多参数是无法识别的,因为无法使用统计标准来唯一确定其估计值。实际上,某些参数的值是固定的,而某些参数是通过数学校准或计算机模拟确定的。这些估计值存在很大的不确定性。本文的第一部分说明了使用迭代加权的非线性最小二乘法拟合药代动力学(PK)模型,突出了在获得不可识别参数的统计估计值和使用自举置信区间来量化不确定性方面的一些常见困难。基于生理学的药代动力学(PBPK)模型中参数的统计估计是一个相对较新的研究领域。在过去的十年左右的时间里,PBPK模型已成为风险评估中重要且有价值的工具,因为这些模型用于描述异物在人体或大鼠等生物系统中的吸收,分布,代谢和排泄。由于这些模型包含有关生物过程的信息,因此它们能够很好地描述化学物质的动力学行为,并且可用于跨剂量途径,物种之间,从高剂量到低剂量以及暴露场景的外推法。根据文献中已发表的模型开发出一种可描述大鼠中二恶英和二恶英样化合物(DLC)的吸收,分布,代谢和排泄的方法。来自国家毒理学计划(NTP)两年实验的数据TR-526用于说明模型拟合和参数的统计估计。将统计方法集成到风险评估中是表征参数值变化的最有效方法。本文采用马尔可夫链蒙特卡罗(MCMC)方法估计系统的选择参数,并描述选择参数的变化。

著录项

  • 作者

    Thompson, Zachary.;

  • 作者单位

    University of South Florida.;

  • 授予单位 University of South Florida.;
  • 学科 Biology Biostatistics.;Biology Physiology.;Health Sciences Pharmacology.
  • 学位 Ph.D.
  • 年度 2012
  • 页码 146 p.
  • 总页数 146
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:43:34

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号